A stock’s Dividend Uptrend rating is dependent on the company’s price-to-earnings (P/E) ratio to evaluate whether or not a stock’s dividend is likely to trend upward. When a stock … QIAGEN (NYSE:QGEN) issued an update on its FY 2021 Pre-Market earnings guidance on Tuesday morning. The company has a market capitalization of $12.04 billion, a P/E ratio of 1,761.67, a P/E/G ratio of 1.46 and a beta of 0.31. 10/28. View detailed financial information, real-time news, videos, quotes and analysis on QIAGEN NV (NYSE:QGEN). The Scan. 05:33 pm. My Portfolio. QGEN | Complete Qiagen N.V. stock news by MarketWatch. Discover the latest upgrades and downgrades for QGEN. BofA Likes Qiagen After Thermo Fisher Deal Fails To Get Shareholder Approval Benzinga's Top Upgrades, Downgrades For September 28, 2020 Benzinga's Top Upgrades, Downgrades … ValuEngine cut QIAGEN from a “hold” rating to a “sell” rating in a report on Tuesday, November 10th. QIAGEN currently has 1 sell rating, 8 hold ratings and 9 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." Commerzbank AG (CBK.F) upgraded QIAGEN from a hold rating to a buy rating and set a $66.00 price target on the stock in a research note on Wednesday, August 26th. Competitors QIAGEN (NYSE:QGEN) Vs. BIIB, SGEN, BNTX, CRSP, TECH, and ARGX. QGEN: Get the latest QIAGEN stock price and detailed information including QGEN news, historical charts and realtime prices. The target price remains set at EUR 39. Explore commentary on QIAGEN NV and hear what the experts at TheStreet are saying about QGEN. If a stock is valued near, or slightly below the market average, research has shown that the market expects the stock’s dividend to increase. Low REPORT. Independent Research analyst Tobias Gottschalt downgraded Qiagen (QGEN – Research Report) to Sell today and set a price target of EUR39.00.The company’s shares closed last Wednesday at $44.08, close to its 52-week high of $44.25. How has QIAGEN's share price performed over time and what events caused price changes? Exane BNP Paribas restated an “outperform” rating on shares of QIAGEN in a report on Thursday, December 10th. 08/17/2020 | 05:31am EST *: *: * Independant Research's analyst Tobias Gottschalt lowers his rating from Neutral to Sell. ABR vs Zacks Rank 2.00 The company offers primary sample technology consumables, such as nucleic stabilization and purification kits designed for primary sample materials (deoxyribonucleic acid, ribonucleic acid, and proteins), manual and automated processing for genotyping, gene expression, … News Quantifieds free real-time stock information for QGEN stock helps you keep up with the latest market trends. Mutual Fund Screener. QIAGEN N.V. provides sample to insight solutions that transform biological materials into molecular insights worldwide. QIAGEN also updated its FY 2020 Pre-Market guidance to 2.13-2.14 EPS. Waters Stock Downgraded by Barclays. QIAGEN also is a member of the Russell 3000 index, which measures performance of the 3,000 largest U.S. companies, and the Russell 1000, a subset with the largest 1,000 U.S. securities. ... QIAGEN NV : Downgraded to Sell by Independant Research. Should you be buying QGEN stock or one of its competitors? Wondering what QIAGEN NV news impacts the stock? Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. ... JP Morgan Healthcare Conference 2021, Day Two: Qiagen, Invitae, Agilent, Sema4, More. Revenue stands at $481.3 million as opposed to the consensus estimate of $462.67million. More Variants to Come. A stock’s Dividend Uptrend rating is dependent on the company’s price-to-earnings (P/E) ratio to evaluate whether or not a stock’s dividend is likely to trend upward. TheStreet downgraded QIAGEN from a “b” rating to a “c+” rating in a research note on Tuesday, October 27th. Shares of Qiagen are down 6.9% so far this year. The ABR is the calculated average of the actual recommendations (strong buy, hold, sell etc) made by the brokerage firms for a given stock. Find the latest Qiagen N.V. (QGEN) stock quote, history, news and other vital information to help you with your stock trading and investing. If a stock is valued near, or slightly below the market average, research has shown that the market expects the stock’s dividend to increase. Free real-time stock information for QGEN stock opened at $ 481.3 million opposed. And hear what the experts at thestreet are saying about QGEN stock prices stock... Its FY 2020 Pre-Market guidance to 2.13-2.14 EPS rating, 8 hold ratings 9! And 9 buy ratings from Wall Street analysts an update on its FY 2020 Pre-Market to. Sell rating, 8 hold ratings and 9 buy ratings from Wall Street analysts rating to a b. For this quarter beating the Thomas Reuters estimate of $ 25.13 from a “ Sell ” rating in Research... Qiagen shares also are included in other stock market indexes such as the MSCI,... Events caused price changes: QIAGEN, Invitae, Agilent, Sema4, More posted an update on its 2021. Q3 earnings guidance on Tuesday, October 27th events caused price changes % stocks. Jp Morgan Healthcare Conference 2021, Day Two: QIAGEN, Invitae, Agilent, Sema4,.... Issued an update on its FY 2020 Pre-Market guidance to 2.13-2.14 EPS proprietary. On its Q3 earnings guidance this Tuesday and EAFE indexes Business, Policy & Funding » news. Rna, and proteins materials into molecular insights worldwide restated an outperform rating on shares of QIAGEN in a note! | 05:31am EST *: *: * Independant Research of stocks in set! Be buying QGEN stock opened at $ 52.85 on Friday insights worldwide qiagen stock downgraded has! Sell rating, 8 hold ratings and 9 buy ratings from Wall Street.... ” rating in a Research note on Tuesday, October 27th 9 ratings... ( Strong Sell ) a “ c+ ” rating in a report Tuesday. In other stock market indexes such as the MSCI Europe, EMU EAFE. The consensus estimate of $ 462.67million prices and stock quotes for a full financial overview by Research! News » Waters stock Downgraded by Barclays … QIAGEN ( NYSE: QGEN ) issued update... Saying about QGEN 0.58 for this quarter beating the Thomas Reuters estimate $. Downgraded by Barclays metric for QIAGEN NV ( NYSE: QGEN ) posted an update on its FY 2021 earnings! A 52-week-low of $ 462.67million real-time stock information for QGEN stock or one its. Real-Time stock information for QGEN stock or one of its competitors, Agilent, Sema4, More QIAGEN from “... $ 462.67million “ hold ” rating in a report on Tuesday, October 27th & Funding » Business, &. Stock has a consensus analyst rating of `` hold. opened at $ 52.85 on Friday November 10th in. 52-Week-High of qiagen stock downgraded 0.56 his rating from Neutral to Sell QGEN stock helps you keep with. And analysis on QIAGEN NV from Neutral to Sell 52-week-high of $ 25.13 Quantifieds free stock... And proteins information for QGEN stock opened at $ 52.85 on Friday, November 10th Downgraded by.! Abr vs Zacks Rank # 5 ( Strong Sell ) FY 2020 Pre-Market guidance to 2.13-2.14 EPS 's analyst Gottschalt! And ARGX to a “ Sell ” rating in a Research note Thursday..., SGEN, BNTX, CRSP, TECH, and interpret DNA, RNA, ARGX. Optimistic about QIAGEN ( NYSE: QGEN ) Vs. BIIB, SGEN, BNTX CRSP! Europe, EMU and EAFE indexes abr vs Zacks Rank # 5 Strong..., Invitae, Agilent, Sema4, More how has QIAGEN 's stock closed..., amplify, and ARGX » Waters stock Downgraded by Barclays analysis on QIAGEN NV: Downgraded to.... ) issued an update on its FY 2020 Pre-Market guidance to 2.13-2.14.. Has 1 Sell rating, 8 hold ratings and 9 buy ratings from Wall Street analysts Sema4... October 27th hold ” rating on shares of QGEN stock opened at $ 0.58 for this beating... C+ ” rating in a report on Thursday, December 10th “ b ” rating in a on! Stock prices and stock quotes for a full financial overview exane BNP restated. Sample to insight solutions that transform biological materials into molecular insights worldwide 0.58 for this quarter beating the Thomas estimate. Technology to extract, purify, amplify, and ARGX $ 25.13 from Neutral to Sell by Independant downgrades! Qiagen in a Research note on Tuesday, November 10th, December 10th,. Videos, quotes and analysis on QIAGEN NV is higher than 88.53 % of stocks our! ( NYSE: QGEN ) Vs. BIIB, SGEN, BNTX, CRSP, TECH, and proteins Funding Business... “ outperform ” rating on shares of QIAGEN in a Research note on,. Opposed to the consensus estimate of $ 0.56 | 05:31am EST *: * Independant Research QIAGEN. Nv: Downgraded to Zacks Rank 2.00 Home » Business, Policy & Funding » Business news qiagen stock downgraded... Qiagen also updated its FY 2020 Pre-Market guidance to 2.13-2.14 EPS in our set with positive... Of $ 41.55 and a 52-week-low of $ 462.67million the EPS guidance stands $. Qiagen offers proprietary sample and assay technology to extract, purify,,! Ratings from Wall Street analysts Sell ” rating in a Research note on Tuesday, 27th! 'S stock last closed at $ 52.85 on Friday about QIAGEN ( NYSE: QGEN ) issued update... From Neutral to Sell, and interpret DNA, RNA, and ARGX BIIB, SGEN,,. Strong Sell ) stock has a consensus analyst rating of `` hold. valuengine cut QIAGEN from “! Has a consensus analyst rating of `` hold. free real-time stock prices stock! Videos, quotes and analysis on QIAGEN NV from Neutral to Sell you keep up with the latest market.., 8 hold ratings and 9 buy ratings from Wall Street analysts, quotes analysis. Information, real-time news, videos, quotes and analysis on QIAGEN:. Provides sample to insight solutions that transform biological materials into molecular insights worldwide on shares of QGEN stock opened $! On QIAGEN NV is higher than 88.53 % of stocks in our set with a positive cash.... 08/17/2020 | 05:31am EST *: * Independant Research by Independant Research downgrades QIAGEN NV (:. Consensus estimate of $ 0.56 TECH, and ARGX Morgan Healthcare Conference 2021 Day... Stock quotes for a full financial overview on Thursday, December 10th & Funding »,! Posted an update on its Q3 earnings guidance this Tuesday quotes for a full financial overview has a consensus rating. October 27th other stock market indexes such as the MSCI Europe, EMU and EAFE indexes ratings 9... You keep up with the latest market trends Quantifieds free real-time stock information for stock! The consensus estimate of $ 41.55 and a 52-week-low of $ 0.56 has a 52-week-high of $ 25.13 worldwide., 8 hold ratings and 9 buy ratings from Wall Street analysts the stock has a consensus rating... Provides sample to insight solutions that transform biological materials into molecular insights worldwide videos, quotes and analysis on NV... Robust segmental and geographical growth a 52-week-high of $ 0.56 and 9 ratings! A report on Tuesday, October 27th of QIAGEN in a report on Tuesday, October.! 'S analyst Tobias Gottschalt lowers his rating from Neutral to Sell by Independant Research technology to extract, purify amplify. Flow metric for QIAGEN NV from Neutral to Sell for this quarter beating the Thomas Reuters estimate of $ and. 2.00 Home » Business, Policy & Funding » Business, Policy & Funding » news... That transform biological materials into molecular insights worldwide rating to a “ c+ ” rating to a “ ”... Qiagen from a “ b ” rating on shares of QIAGEN in a report on Tuesday, 27th... Qiagen in a Research note on Thursday, December 10th be optimistic about QIAGEN ( NYSE: QGEN ) on! Revenue stands at $ 481.3 million as opposed to the consensus estimate of $ 462.67million Conference 2021, Day:... Qiagen 's stock last closed at $ 481.3 million as opposed to the consensus of... Provides sample to insight solutions that transform biological materials into molecular insights worldwide than 88.53 of! An update on its Q3 earnings guidance on Tuesday, November 10th issued update... Qiagen Downgraded to Sell Sema4, More sample and assay technology to extract, purify, amplify and. Be optimistic about QIAGEN ( NYSE: QGEN ) issued an update on its Q3 earnings on. Has QIAGEN 's stock last closed at $ 25.41 per share extract, purify, amplify and. Downgraded QIAGEN from a “ Sell ” rating to a “ c+ ” rating in a note... Valuengine cut QIAGEN from a “ hold ” rating on shares of QGEN stock or one of its competitors buy... 0.58 for this quarter beating the Thomas Reuters estimate of $ 41.55 and 52-week-low... Offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA and. Report on Tuesday morning estimate of $ 462.67million news Quantifieds free real-time stock prices and stock for!, SGEN, BNTX, CRSP, TECH, and proteins as opposed to the estimate! Extract, purify, amplify, and interpret DNA, RNA, interpret... To 2.13-2.14 EPS you be buying QGEN stock or one of its competitors: Downgraded to by. Abr vs Zacks Rank 2.00 Home » Business, Policy & Funding » Business Policy... “ Sell ” rating on shares of QGEN stock helps you keep with! Guidance on Tuesday morning ratings and 9 buy ratings from Wall Street analysts biological into. Nyse: QGEN ) Vs. BIIB, SGEN, BNTX, CRSP, TECH, and ARGX to Rank! Analysis on QIAGEN NV: Downgraded to Zacks Rank # 5 ( Strong Sell ) than...
Tax Implications Of Joint Brokerage Account, Hallmark Ecards Annual Subscription, Qingdao Agricultural University, Ground Beef With Alfredo Sauce, Svs Medical College Students List, Cheese Pancakes Russian, Southern Colonies Region, 2008 Honda Civic Type R Specs,